| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/17/2011 | CN102159561A Glycoside derivatives and uses thereof |
| 08/17/2011 | CN102159554A Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists |
| 08/17/2011 | CN102159545A Small molecule leptin receptor modulators |
| 08/17/2011 | CN102159542A New compounds vii |
| 08/17/2011 | CN102159228A Composition comprising a hot water extract of hemerocallis plants, said composition being effective in treating fatigue by having antidepressant properties or by improving sleep |
| 08/17/2011 | CN102159222A Bioactive agent,pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent |
| 08/17/2011 | CN102159215A Treating various disorders using trkb agonists |
| 08/17/2011 | CN102159206A Glucoside derivatives and uses thereof as sglt inhibitors |
| 08/17/2011 | CN102159200A Novel sulphur containing lipids for use as food supplement or as medicament |
| 08/17/2011 | CN102154299A Preparation method of oral medicament active peptide from shark liver for treating diabetes |
| 08/17/2011 | CN102154238A Lipase capable of effectively reducing cholesterol level and blood fat level of human body and application thereof |
| 08/17/2011 | CN102154237A Lipase capable of reducing cholesterol and blood fat levels in bodies of animals and use thereof |
| 08/17/2011 | CN102154210A Method for preparing hepatic stem cell decorated by insulin gene and application and preparation thereof |
| 08/17/2011 | CN102153676A Method for removing organic residue in heparin sodium through vacuum drying |
| 08/17/2011 | CN102153672A Method for extracting chondroitin sulfate |
| 08/17/2011 | CN102153652A Expression method and application of fusion protein |
| 08/17/2011 | CN102153641A Preparation method and application of mutain of human insulin-like growth factor binding protein 7 (IGFBP7) |
| 08/17/2011 | CN102153630A Ring octapeptide and preparation method and application thereof in medicament making |
| 08/17/2011 | CN102153543A Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 08/17/2011 | CN102153540A Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 08/17/2011 | CN102153538A Benzocyclodirivative |
| 08/17/2011 | CN102153536A Mangiferin aglycon derivative, as well as preparation method and application of the mangiferin aglycon derivative |
| 08/17/2011 | CN102153534A Compound with tyrosinase inhibitory activity as well as preparation method and application thereof |
| 08/17/2011 | CN102153504A Method for preparing 1-deoxynojirimycin in mulberry leaves |
| 08/17/2011 | CN102151337A Compositions and methods for regulated protein expression in gut |
| 08/17/2011 | CN102151335A Regulation of metabolism by protein lysine acetylation modification |
| 08/17/2011 | CN102151326A Combined Chinese medicine for curing hypertension and hyperlipaemia |
| 08/17/2011 | CN102151313A Tonghua sugar conversion liquid |
| 08/17/2011 | CN102151296A Method for extracting active ingredients for reducing sugar blood from waste residues of liquorice |
| 08/17/2011 | CN102151294A Heat-nourishing sedum kamtschaticum and cordyceps militaris wine |
| 08/17/2011 | CN102151291A Use of antrodia camphorata for treating diseases |
| 08/17/2011 | CN102151285A Neutral calcium supplement preparation |
| 08/17/2011 | CN102151284A Composition containing fucoidin sulfate and application thereof |
| 08/17/2011 | CN102151281A Flavonoid compound for preventing and treating diabetes and medicament application thereof |
| 08/17/2011 | CN102151262A Compounds for the treatment of metabolic disorders |
| 08/17/2011 | CN102151260A Andrographolide and berberine combination and application thereof |
| 08/17/2011 | CN102151259A Methods for purifying trans-(-)-[delta]9-tetrahydrocannabinol and trans-(+)-[delta]9-tetrahydrocannabinol |
| 08/17/2011 | CN102151252A Glipizide osmotic pump type controlled release tablet |
| 08/17/2011 | CN102150851A Sea cucumber saponin, preparation method thereof and application thereof in food or medicine |
| 08/17/2011 | CN102150845A Polysaccharide nutritional product and preparation method and application thereof |
| 08/17/2011 | CN102150844A Dried noodles with function of treating diabetes and preparation method of dried noodles |
| 08/17/2011 | CN102150838A Weight losing composition, preparation containing same and preparation method thereof |
| 08/17/2011 | CN102150829A Nanometer fig royal jelly |
| 08/17/2011 | CN102150716A Medicinal tea with function of treating diabetes and preparation method thereof |
| 08/17/2011 | CN102150692A Biscuit with function of curing diabetes and preparation method thereof |
| 08/17/2011 | CN101884760B Chinese medicinal composition for treating diabetes mellitus and preparation method thereof |
| 08/17/2011 | CN101756993B Medical composition for losing weight or treating metabolic syndromes |
| 08/17/2011 | CN101744847B Agaricus compound polysaccharide capsule preparation method |
| 08/17/2011 | CN101693034B Diffractive-ring mangiferin A in mango leaves and new application of mango leaf extractives containing diffractive-ring mangiferin A |
| 08/17/2011 | CN101690766B Gentle bath foam traditional Chinese medicine composite, preparation method thereof and application thereof in preparing drugs and health care products to cure cold-type fatigue syndrome and obesity |
| 08/17/2011 | CN101664510B Coordination bath lotion composition, preparation method and application in preparing pharmaceuticals and health products for treating cold and heat illegibility type fatigue syndrome or adiposity |
| 08/17/2011 | CN101612234B Traditional Chinese medicine processing method |
| 08/17/2011 | CN101591321B Method for preparing 5,6,7,4'-tetrahydroxyflavone |
| 08/17/2011 | CN101455794B Use of highland barley bran |
| 08/17/2011 | CN101455655B Creatine sustained-release preparation and preparation process thereof medication |
| 08/17/2011 | CN101444549B Composition of plant extracts for preventing or curing metabolism disorder of blood lipid and application thereof |
| 08/17/2011 | CN101434660B Method for extracting Ganoderma lucidum polysaccharide by ultrasonic wave-microwave combination |
| 08/17/2011 | CN101375972B Health oral liquid and its preparation |
| 08/17/2011 | CN101347511B Medicament composition with function for reducing blood sugar |
| 08/17/2011 | CN101301386B Oral liquid of Wuqingtongti and preparation thereof |
| 08/17/2011 | CN101230059B Bicycle aza alkyl derivative, preparation method and use in medicine thereof |
| 08/17/2011 | CN101041693B Novel blood sugar lowing polypeptide and uses thereof |
| 08/17/2011 | CN100998674B Traditional Chinese medicine composition with functions of lowering blood-fat and reducing weight |
| 08/16/2011 | US7999109 CCR9 inhibitors and methods of use thereof |
| 08/16/2011 | US7998986 Heterocyclic compounds, in particular N-substituted pyridones for modulating the activity of nuclear receptors |
| 08/16/2011 | US7998975 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 08/16/2011 | US7998959 Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same |
| 08/16/2011 | US7998953 Myocardial infarction or its recurrence is treated with telmisartan an ACE inhibitor |
| 08/16/2011 | US7998931 Vascular endothelial cell growth factor antagonists and uses thereof |
| 08/16/2011 | US7998928 Method of treatment of type-1 diabetes with a humanin analogue |
| 08/16/2011 | US7998922 Process for treating fibroses with biocompatible polymer |
| 08/16/2011 | CA2614603C Azolo triazines and pyrimidines |
| 08/16/2011 | CA2557163C Substituted 1,2,3,4-tetrahydroisoquinoline derivatives |
| 08/16/2011 | CA2487095C Elongase genes and uses thereof |
| 08/16/2011 | CA2482655C Substituted indoles |
| 08/16/2011 | CA2468248C Pregnane steroids for use in the treatment of cns disorders |
| 08/16/2011 | CA2397590C Antisense inhibition of ptp1b expression |
| 08/16/2011 | CA2382941C Use of leptin in inhibition of endothelial cell proliferation |
| 08/16/2011 | CA2354325C Growth factor homolog zvegf3 |
| 08/11/2011 | WO2011097500A2 The tweak/fn14 system regulates skeletal muscle atrophy and regeneration |
| 08/11/2011 | WO2011097336A2 Highly selective 5-ht(2c) receptor agonists having antagonist activity at the 5-ht(2b) receptor |
| 08/11/2011 | WO2011097079A1 Apoptosis signal-regulating kinase 1 inhibitors |
| 08/11/2011 | WO2011096808A1 Use of sialyl oligosaccharides in weight management |
| 08/11/2011 | WO2011096490A1 Imidazopyridin-2-one derivative |
| 08/11/2011 | WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases |
| 08/11/2011 | WO2011096462A1 Heterocyclic compound having npy y5 receptor antagonistic activity |
| 08/11/2011 | WO2011096461A1 Quinoline derivative |
| 08/11/2011 | WO2011096414A1 Mitochondrial function improver |
| 08/11/2011 | WO2011096413A1 Agent for improving motility function |
| 08/11/2011 | WO2011096377A1 Pyrrole compound |
| 08/11/2011 | WO2011096360A1 Method for treatment of lacto-n-biose-containing solution |
| 08/11/2011 | WO2011095997A1 Benzamide compounds as glucokinase activators and their pharmaceutical application |
| 08/11/2011 | WO2011095095A1 Medicinal composition comprising alcohol-soluble and water-insoluble licorice extract, pharmaceutical preparation, pharmaceutical application, therapeutic method, and preparative method thereof |
| 08/11/2011 | WO2011095050A1 C-glycoside derivatives containing saturated 6-member rings, preparation methods and uses thereof |
| 08/11/2011 | WO2011094890A1 Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators |
| 08/11/2011 | WO2011048479A3 Compositions that include anthocyanidins and methods of use |
| 08/11/2011 | WO2011047530A8 Carotenoid derivatives, preparation method and use thereof |
| 08/11/2011 | WO2011043630A9 Composition for preventing and treating obesity diseases containing highly water-soluble 2-hydroxypropyl-β-cyclodextrin as active ingredient |
| 08/11/2011 | WO2011038014A3 Composition and method for treatment of diabetes |
| 08/11/2011 | WO2011036316A3 Use of plant extracts as prebiotics, compostions and foods containing such extracts |